AJMC July 3, 2024
Pearl Steinzor

Primary causes of the cancer drug shortage include manufacturing issues, supply chain disruptions, and regulatory delays, says Crystal S. Denlinger, MD, FACP, CEO of the National Comprehensive Cancer Network (NCCN).

Recently, the NCCN released a survey of best practices for drug shortage management.

Transcript

What are the primary causes of the current cancer drug shortage, and are there any specific trends or events that have exacerbated the situation?

This is a great question, and I think that the current cancer drug shortage is actually just an extension of a drug shortage that’s been going on for a while across different generic medications. The causes are primarily related to supply chain issues, and a supply chain that has little redundancy or...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Biotechnology, Clinical Trials, Conferences / Podcast, Pharma, Pharma / Biotech, Trends
FDA approves clinical trials for pig organ transplants
Supply chains and AI take precedence at European clinical trial meeting
Clinical trial: New drug combination reduces anemia in rare blood disorder
Transforming Clinical Trials with Alexander Saint-Amand
The New Product Development Landscape: Navigating the Challenges

Share This Article